THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (MAPP OR CONTRACTOR) IS FOR THE DEVELOPMENT OF MAPP?S THERAPEUTIC INTERVENTION MBP091, AS AN IMMUNOTHERAPY FOR THE TREATMENT OF MARBURG VIRUS INFECTION.
$155,212,688
| Recipient | MAPP BIOPHARMACEUTICAL, INC. UEI M9V9QTHR1H28 |
|---|---|
| Award ID | 75A50122C00076 |
| Award amount | $155,212,688 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN13 |
| Set-aside | Unrestricted |
| Start date | Sep 28, 2022 |
| End date | Dec 31, 2032 |
| Place of performance | SAN DIEGO, CA |
| Record updated | Sep 14, 2026 |
View the official award record
More awards won by MAPP BIOPHARMACEUTICAL, INC.
PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES
Department of Health and Human Services · $223,292,319 · Sep 30, 2022
IGF::OT::IGF
Department of Health and Human Services · $55,836,771 · Sep 25, 2018
MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPP
Department of Health and Human Services · $28,870,288 · Jun 27, 2016
DEVELOPMENT OF A PAN-BOTULINUM NEUROTOXIN MEDICAL COUNTERMEASURE
Department of Health and Human Services · $16,413,163 · Sep 30, 2020
IGF::OT::IGF
Department of Health and Human Services · $7,486,451 · Sep 13, 2017
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids